There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on INDUS Realty Trust (INDT – Research Report), UDR (UDR – Research Report) and AdaptHealth (AHCO – Research Report) with bullish sentiments.
INDUS Realty Trust (INDT)
Robert W. Baird analyst Dave Rodgers maintained a Buy rating on INDUS Realty Trust on November 8 and set a price target of $61.00. The company’s shares closed last Wednesday at $53.20, close to its 52-week low of $48.33.
According to TipRanks.com, Rodgers is a 2-star analyst with an average return of
Currently, the analyst consensus on INDUS Realty Trust is a Moderate Buy with an average price target of $73.00.
See the top stocks recommended by analysts >>
UDR (UDR)
Robert W. Baird analyst Wes Golladay maintained a Buy rating on UDR on November 7 and set a price target of $47.00. The company’s shares closed last Wednesday at $37.56, close to its 52-week low of $37.22.
According to TipRanks.com, Golladay is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for UDR with a $46.11 average price target.
AdaptHealth (AHCO)
In a report issued on November 8, Eric Coldwell from Robert W. Baird reiterated a Buy rating on AdaptHealth, with a price target of $31.00. The company’s shares closed last Wednesday at $20.72.
According to TipRanks.com, Coldwell is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for AdaptHealth with a $29.13 average price target, representing a 39.9% upside. In a report released yesterday, Canaccord Genuity also maintained a Buy rating on the stock with a $28.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on INDT:
- Analysts’ Opinions Are Mixed on These Services Stocks: Choice Hotels (CHH), TaskUs (TASK) and Portillo’s (PTLO)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), BioMarin Pharmaceutical (BMRN) and Intellia Therapeutics (NTLA)
- Robert W. Baird Sticks to Its Hold Rating for Physicians Realty (DOC)
- Robert W. Baird Sticks to Its Buy Rating for Planet Fitness (PLNT)
- Robert W. Baird Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)
